[Federal Register: December 8, 2008 (Volume 73, Number 236)]
[Notices]
[Page 74523]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08de08-71]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By notice dated February 20, 2008, and published in the Federal
Register on February 29, 2008 (73 FR 11149), Supernus Pharmaceuticals,
1550 East Gude Drive, Rockville, Maryland 20850, made application to
the Drug Enforcement Administration (DEA) to be registered as an
importer of the basic classes of controlled substances listed in
schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Oxycodone (9143)........................... II
Morphine (9300)............................ II
------------------------------------------------------------------------
The company plans to import controlled substances for clinical
trials and analytical testing.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Supernus Pharmaceuticals to import the basic classes of
controlled substances is consistent with the public interest and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971, at this time. DEA has investigated
Supernus Pharmaceuticals to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34,
the above named company is granted registration as an importer of the
basic classes of controlled substances listed.
Dated: November 26, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-28987 Filed 12-5-08; 8:45 am]
BILLING CODE 4410-09-P